A partial reduction in serum estradiol was observed in OVX-PBS-treated mice relative to sham, although this did not reach statistical significance (Figure 2A ).
← all excerpts
Aromatase inhibitor-induced bone loss increases the progression of estrogen receptor-negative breast cancer in bone and exacerbates muscle weakness in vivo.
1
—
—